11:42 AM EST - Concordia Healthcare Corp. : entered into a definitive agreement with Cinven, a leading European private equity firm, and certain funds managed by it and certain other persons, to acquire Amdipharm Mercury Limited for approximately $3.5 billion U.S. to be paid through a combination of cash, common shares of Concordia, and performance-based earn-out payable in cash. Concordia Healthcare Corp.
shares T.CXR are trading down $9.24 at $101.36.
